Development of plasma kallikrein selective inhibitors-Reference-Cited by-同舟云学术

Development of plasma kallikrein selective inhibitors

Published:1999 Issue:1 Volume:51 Page:41-50
ISSN:0006-3525
Container-title:Biopolymers
language:en
Short-container-title:Biopolymers

Author:

Okada Yoshio,Tsuda Yuko,Tada Mayako,Wanaka Keiko,Hijikata-Okunomiya Akiko,Okamoto Utako,Okamoto Shosuke

Publisher

Wiley

Subject

Organic Chemistry,Biomaterials,Biochemistry,General Medicine,Biophysics

Reference45 articles.

1. ; ; In Hemostasis and Throbosis: Basic Principles and Clinical Practice, 3rd ed.; Eds.; J. B. Lippincott Company: Philadelphia, PA, 1994; pp 219-240.

2. Separation of a New Substrate, Kininogen-I, for Plasma Kallikrein in Bovine Plasma*

3. ACTIVATION OF HAGEMAN FACTOR IN SOLID AND FLUID PHASES

4. Activation of plasminogen by human plasma kallikrein

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Identifying Circulating Urotensin II and Urotensin II-Related Peptide-Generating Enzymes in the Human Plasma Fraction Cohn IV-4;Journal of Proteome Research;2021-11-04

2. Serine Protease Inhibitors to Treat Lung Inflammatory Diseases;Advances in Experimental Medicine and Biology;2021

3. Plasma kallikrein activates the epithelial sodium channel in vitro but is not essential for volume retention in nephrotic mice;Acta Physiologica;2018-03-25

4. Serine protease inhibitors to treat inflammation: a patent review (2011-2016);Expert Opinion on Therapeutic Patents;2017-12-05

5. Design of Specific Serine Protease Inhibitors Based on a Versatile Peptide Scaffold: Conversion of a Urokinase Inhibitor to a Plasma Kallikrein Inhibitor;Journal of Medicinal Chemistry;2015-11-12